Skye Bioscience Inc. (SKYE) Live Share Price, Invest From India

Skye Bioscience Inc. Stock Performance

as on June 27, 2026 at 2:16 pm IST

Day's High
$0.68
Day's Price Range
$0.74
$0.68
8.82%
Upside
52 Week's Low
52 Week's High
$0.57
52-Week Price Range
$5.75
$0.68
16.84%
Downside
745.59%
Upside

Skye Bioscience Inc. share price movements today

Previous Close: $0.71
Open: $0.70
Volume: 299.4K
Day's Low - High: $0.68 - $0.74
52 Week Low - High: $0.57 - $5.75

Skye Bioscience Inc. Historical Returns

1 Month Return: -13.83 %
3 Month Return: + 14.63 %
1 Year Return: -83.33 %
3 Year Return: -88.39 %
5 Year Return: 0 %

Skye Bioscience Inc. Stock Fundamentals & Key Indicators

Check Skye Bioscience Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$23.9M

EPS (TTM)

-1.046

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-167.97%

Skye Bioscience Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Skye Bioscience Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Skye Bioscience Inc.	NA	$23.9M	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$39.3B	67.15%	74.07	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$120.6B	147.08%	28.17	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$65.4B	12.64%	15.22	29.65%	0.58%

Stock Returns calculator for Skye Bioscience Inc. Stock including INR - Dollar returns

The Skye Bioscience Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Skye Bioscience Inc. investment value today

Current value as on today

₹17,606

Returns

-₹82,394

(-82.39%)

Returns from Skye Bioscience Inc. Stock

-₹84,000 (-84%)

Dollar Impact

₹1,606 (+1.61%)

Indian Investors' Interest in Skye Bioscience Inc. Stock

Search interest for Skye Bioscience Inc. Stock has increased by 43% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 30, 2026 to June 29, 2026

Change:43% versus previous 30 day period

Skye Bioscience Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	-	0	0
Operating Income	-4	-6	-8	-4	-10	-11	-18	-13	-14	-12
EBITDA	-3	-4	-7	-3	-9	-10	-17	-12	-14	-12
Interest Expense	0	0	0	0	0	0	-	-	-	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-5	-7	-3	-9	-11	-17	-12	-14	-12
Income Tax Expense	0	0	0	-	-	0	0	-	-	-
Net Income	-4	-5	-7	-3	-9	-11	-17	-12	-14	-12
Net Profit Margin	-2705.16%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Skye Bioscience Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0
Operating Income	-3	-4	-6	-6	-7	-18	-34	-30	-58
EBITDA	-3	-4	2	-5	-7	-18	-36	-25	-55
Interest Expense	0	0	1	0	0	0	0	0	-
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-3	-19	1	-6	-8	-19	-37	-26	-55
Income Tax Expense	0	0	0	0	0	0	0	0	0
Net Income	-3	-19	1	-6	-8	-19	-37	-26	-55
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Skye Bioscience Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-5	-7	-3	-9	-11	-17	-12	11,077	-12
Operating Cash Flow	-4	-7	-5	-8	-9,185	-10	-13	-9	-8
Investing Cash Flow	1	0	-1	0	-12,808	-11	7	-2	10
Financing Cash Flow	85	-2	-	0	-	0	-	0	0
Change in Cash	82	-9	-6	-8	-21,994	-22	-5	-12	2

Skye Bioscience Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-3	-19	1	-6	-8	-19	-37	-26	-55
Operating Cash Flow	-3	-3	-6	-6	-6	-12	-13	-25	-43
Investing Cash Flow	0	0	0	0	0	5	6	0	-19
Financing Cash Flow	3	5	6	6	13	0	16	83	0
Change in Cash	0	1	0	0	6	-7	9	58	-62

Global Institutional Holdings in Skye Bioscience Inc.

Funds	Holdings
HRT FINANCIAL LLC	0.08%
Versant Venture Management LLC	5.72%
Sphera Funds Management Ltd.	1.93%
Jane Street Group LLC	0.07%
BlackRock Inc	0.81%

See all

Insights on Skye Bioscience Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Skye Bioscience, Inc. Common Stock has experienced a drawdown of -87.6%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 78.0%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 21.5% return, outperforming this stock by 105.0%
NEGATIVE IMPACT
Price Dip
In the last 1 year, SKYE stock has moved down by -83.5%

About Skye Bioscience Inc.

Skye Bioscience, Inc., a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. is headquartered in San Diego, California.

Organisation	Skye Bioscience Inc.
Headquarters	11250 El Camino Real, San Diego, CA, United States, 92130
Industry	Biotechnology
CEO	Mr. Punit S. Dhillon B.A.
E-voting on shares	Click here to vote

Key Management of Skye Bioscience Inc.

Name	Title
Mr. Punit S. Dhillon B.A.	President, CEO & Director
Mr. Tu Diep M.Sc.	Chief Operating Officer
Mr. John P. Sharp CPA	CFO and Principal Financial & Accounting Officer
Dr. Christopher G. Twitty Ph.D.	Chief Scientific Officer
Dr. Puneet S. Arora FACE, M.D., M.S.	Chief Medical Officer

FAQs

What is Skye Bioscience Inc. share price today?

Skye Bioscience Inc. share price today is $0.68 as on June 27, 2026 at 8:46 am IST at the close of the market. Skye Bioscience Inc. share today touched a day high of $0.74 and a low of $0.68.

What is the 52 week high and 52 week low for Skye Bioscience Inc. share?

Skye Bioscience Inc. share touched a 52 week high of $5.75 on June 27, 2025 and a 52 week low of $0.57 on March 30, 2026. Skye Bioscience Inc. stock price today i.e. June 27, 2026 at 8:46 am IST is closed at $0.68,which is 88.17% down from its 52 week high and 20.25% up from its 52 week low.

What is Skye Bioscience Inc.'s market capitalisation today?

Skye Bioscience Inc. market capitalisation is $0.00T as on June 27, 2026 at 8:46 am IST.

How to invest in Skye Bioscience Inc. Stock (SKYE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Skye Bioscience Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Skye Bioscience Inc. Shares that will get you 2.2059 shares as per Skye Bioscience Inc. share price of $0.68 per share as on June 27, 2026 at 8:46 am IST.

What is the minimum amount required to buy Skye Bioscience Inc. Stock (SKYE) from India?

Indian investors can start investing in Skye Bioscience Inc. (SKYE) shares with as little as ₹94.3 or $1 (as of June 29, 2026 at 2:57 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Skye Bioscience Inc. stock (as per the Rupee-Dollar exchange rate as on June 29, 2026 at 2:57 am IST). Based on Skye Bioscience Inc. share’s latest price of $0.68 as on June 27, 2026 at 8:46 am IST, you will get 14.7059 shares of Skye Bioscience Inc.. Learn more about fractional shares .